NCT06385431View on ClinicalTrials.gov

Obeservational Cohort for Evaluating Future Cardiovascular Disease With High Metabolic Risks

Not yet recruitingOBSERVATIONAL
Enrollment

8,000

Participants

Timeline

Start Date

April 28, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Metabolic Disease
Interventions
OTHER

observational study

obeservational study with none intervention

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT06385431 - Obeservational Cohort for Evaluating Future Cardiovascular Disease With High Metabolic Risks | Biotech Hunter | Biotech Hunter